Skip to content

Clinical trials

Completed Stress Disorders, Post-Traumatic trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stress Disorders, Post-Traumatic Phase: Not applicable Status: Completed Clear all

952 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20025
20033
200411
20058
200614
200711
200835
200932
201028
201132
201257
201345
201449
201552
201661
201759
201859
201976
202070
202175
202254
202348
202431
202524
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed952

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
VA Office of Research and Development124
US Department of Veterans Affairs23
University of Washington20
Duke University18
University of Konstanz17
Medical University of South Carolina15
The University of Texas Health Science Center at San Antonio13
Stanford University11
Karolinska Institutet9
Rush University Medical Center8

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stress Disorders, Post-Traumatic952
Anxiety Disorders159
Wounds and Injuries81
Substance-Related Disorders60
Combat Disorders40
Major Depressive Disorder28
Sleep Initiation and Maintenance Disorders28
Alcoholism25
Brain Injuries, Traumatic24
Chronic Pain22

Trials

Showing 1 to 25 of 952. Each trial links to its page on Pharma Observatory.

852 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.